New Jersey is considering passing a new rule that would limit a physician’s compensation received from pharma companies at $10,000 a calendar year.  However, according to ACRO (Association of Clinical Research Organizations), if not modified, this ceiling would also include clinical trial payments and would make it impossible to enroll a single patient in many trials, as the cost per patient of a cancer trial is around $10,000 to $20,000. A recent bill passed in California restricts such payments but leaves clinical trials out. (FierceBiotech)